Recent trends in intensity-modulated radiation therapy use in Korea
- Author:
Seung Jae HUH
1
;
Won PARK
;
Do Ho CHOI
Author Information
- Publication Type:Original Article
- Keywords: Intensity-modulated radiotherapy; Korea
- MeSH: Breast; Breast Neoplasms; Gyeonggi-do; Humans; Incheon; Insurance; Korea; Lung; National Health Programs; Prostatic Neoplasms; Radiotherapy, Intensity-Modulated
- From:Radiation Oncology Journal 2019;37(4):249-253
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: We aimed to analyze the trend in intensity-modulated radiation therapy (IMRT) use in Korea from 2011 to 2018.MATERIALS AND METHODS: We collected data from the Health and Insurance Review and Assessment Service (HIRA) big data based on the National Health Insurance Service claims and reimbursements records using primary treatment planning codes (HD 041) for IMRT from 2011 to 2018. We analyzed the changing patterns in clinical application to specific tumor sites and regional differences in IMRT utilization.RESULTS: The use of IMRT has exhibited an 18-fold steep rise from 1,921 patients in 2011 to 34,759 in 2018. With regard to IMRT in 2018, 70% of patients (24,248/34,759) were treated in metropolitan areas (Seoul, Incheon, and Gyeonggi Province). IMRT was most commonly used to treat breast, lung, and prostate cancers in 2018. Among these, the use of IMRT for breast cancer shows the most remarkable increase from 2016 when the National Health Insurance began to cover IMRT for all solid tumors.CONCLUSION: The use of IMRT is steadily increasing to treat cancer and is concentrated in metropolitan areas.
